Faculty of Medicine
Research
Research
Our department actively conducts clinical research on primary lung cancer, addressing rapid advances introduced by molecular targeted therapies and immune checkpoint inhibitors. Cases once considered unresectable may now be eligible for surgery after pharmacotherapy, widening treatment options. We continuously evaluate these interventions, optimizing efficacy and timing based on extensive data on post-operative recurrence. By maintaining comprehensive databases and actively participating in multicenter trials—e.g., the Japan North East Thoracic Surgeon Study Group (JNETS)—we aim to lead nationwide studies and deliver optimal care. With roots as a pharmacy-focused institution, we excel in new drug development and interdisciplinary pharmaceutical research, thus furthering personalized medicine and effective management of adverse events.
Concurrently, we are establishing treatment strategies for refractory pneumothorax. Drawing on long-term outcomes from both primary spontaneous and secondary pneumothorax, we propose multidisciplinary approaches in areas lacking clear guidelines. Our overarching goal is to enhance quality of life through a long-term perspective, incorporating therapeutic courses and recurrence risks while collaborating with facilities across the country to strengthen clinical evidence.
In addition, our experience with ex vivo lung perfusion (EVLP)—where donor lungs are perfused outside the body for preservation, re-evaluation, and therapy—underpins our cooperative research with institutions including the National Institute of Advanced Industrial Science and Technology, Tohoku University, Tokyo Science University, and Kyoto University. We conduct large-animal experiments with Tohoku University, and organ-based studies at our own medical school. Our efforts aim to preserve pulmonary function and reduce injury under various conditions, ultimately improving transplantation techniques, decreasing postoperative complications, and advancing therapy for severe respiratory failure, thereby promoting progress in thoracic surgery.
We all in the Center for Medical Education are widely in charge of medical education such as medical lectures and trainings of both basic medical sciences and clinical medicine. Through these educational experiences, we are generally responsible for coordinating the medical education of all grades. Also, based on a PDCA cycle system, we plan to improve the curriculum of medical education in cooperation with members in Faculty of Medicine. To make a cornerstone of under- and postgraduate education, we promote research in the medical education with analysis of data from educational action. In addition, we have our own original research background; and conduct our research as well.